Related Experiment Videos
Summary
Certain drugs can cause folate deficiency by inhibiting dihydrofolate reductase or through uncertain mechanisms, potentially leading to megaloblastic anemia. Folic or folinic acid may help manage these effects.
Area of Science:
- Biochemistry
- Nutritional Science
- Pharmacology
Background:
- Folates are essential dietary compounds crucial for DNA, amino acid, and amine metabolism.
- Biologically active folates are tetrahydrofolates, synthesized by dihydrofolate reductase.
- Several drugs interfere with folate metabolism, leading to deficiency.
Purpose of the Study:
- To review the mechanisms by which drugs induce folate deficiency.
- To discuss the clinical manifestations, such as megaloblastic anemia.
- To explore potential therapeutic interventions for drug-induced folate deficiency.
Main Methods:
- Review of existing literature on folate metabolism and drug interactions.
- Analysis of mechanisms of folate antagonism by specific drugs.
- Examination of clinical outcomes and treatment strategies for folate deficiency.
Main Results:
- Folate antagonists (e.g., methotrexate) inhibit dihydrofolate reductase, causing deficiency.
- Other drugs (e.g., anticonvulsants) may reduce folate absorption or alter metabolism.
- Megaloblastic anemia is a known consequence, treatable with folinic acid.
- Neurological and psychiatric effects of folate deficiency are less certain but may respond to folic/folinic acid therapy.
Conclusions:
- Drug-induced folate deficiency is a significant clinical concern.
- Understanding the mechanisms is key to prevention and management.
- Folic and folinic acid are vital for treating folate deficiency and its complications.